News

Celltrion Announces U.S. FDA Approval Of Additional Presentation Of STEQEYMA® (Ustekinumab-Stba), Expanding Dosing Options For Pediatric Patients
Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with p ...